Patents by Inventor Adrian Recinos

Adrian Recinos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and biomarkers for the detection of dengue hemorrhagic fever
    Patent number: 10168337
    Abstract: The present invention provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patient with risk of DHF. More particularly, the invention provides plasma biomarkers including complement factor D to complement factor H (FactorD/FactorH) ratio and levels of one or more of IL2, desmoplakin, and high molecular weight albumin, which are used to detect risk of developing DHF.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: January 1, 2019
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Allan Brasier, Adrian Recinos, John E. Wiktorowicz, Heidi Spratt, Hyunsu Ju, Nikos Vasilakis, Ernesto E. T. Marquez, Marli Tenorio, Laura H. V. G. Gil, Eduardo Nascimento
  • Method and Biomarkers for the Detection of Dengue Hemorrhagic Fever
    Publication number: 20160003845
    Abstract: The present invention provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patient with risk of DHF. More particularly, the invention provides plasma biomarkers including complement factor D to complement factor H (FactorD/FactorH) ratio and levels of one or more of IL2, desmoplakin, and high molecular weight albumin, which are used to detect risk of developing DHF.
    Type: Application
    Filed: June 6, 2012
    Publication date: January 7, 2016
    Applicant: The Board of Regent of the University of Texas System
    Inventors: Allan Brasier, Adrian Recinos, John E. Wiktorowicz, Heidi Spratt, Hyunsu Ju, Nikos Vasilakis, Ernesto E.T. Marquez, Marli Tenorio, Laura H. V. G. Gil, Eduardo Nascimento
  • METHOD AND BIOMARKERS FOR THE DETECTION OF DENGUE HEMORRHAGIC FEVER
    Publication number: 20150316562
    Abstract: The present invention provides methods for detecting, analyzing, and identifying biomolecules used to identifying patient with dengue-like symptom who are at risk of DHF. The inventive method comprises detecting in a sample from a subject dengue infected patient one or more biomarkers selected from the group consisting of IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, and which are used in a predictive MARS model to detect patients with risk of developing DHF.
    Type: Application
    Filed: July 15, 2015
    Publication date: November 5, 2015
    Inventors: Tadeusz KOCHEL, Josephina Nores GARCIA, Allan BRASIER, Adrian RECINOS, John E. WIKTOROWICZ, Heidi SPRATT, Hyunsu JU
  • Methods and biomarkers for the detection of dengue hemorrhagic fever
    Patent number: 9103826
    Abstract: The present invention provides methods for detecting, analyzing, and identifying biomolecules used to identifying patient with dengue-like symptom who are at risk of DHF. The inventive method comprises detecting in a sample from a subject dengue infected patient one or more biomarkers selected from the group consisting of IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, and which are used in a predictive MARS model to detect patients with risk of developing DHF.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: August 11, 2015
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Tadeusz Kochel, Josefina Nores Garcia, Allan Brasier, Adrian Recinos, John E. Wiktorowicz, Heidi Spratt, Hyunsu Ju
  • Methods and Biomarkers for the Detection of Dengue Hemorrhagic Fever
    Publication number: 20130004473
    Abstract: The present invention provides methods for detecting, analyzing, and identifying biomolecules used to identifying patient with dengue-like symptom who are at risk of DHF. The inventive method comprises detecting in a sample from a subject dengue infected patient one or more biomarkers selected from the group consisting of IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, and which are used in a predictive MARS model to detect patients with risk of developing DHF.
    Type: Application
    Filed: June 6, 2012
    Publication date: January 3, 2013
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Tadeusz Kochel, Josefina Nores Garcia, Allan Brasier, Adrian Recinos, John E. Wiktorowicz, Heidi Spratt, Hyunsu Ju